BMS

The rounds this investor is named on, who it invests beside, and where it shows up.

Named on one round in the feed.

Since 2026-09-28

ROUNDS

joined, none as lead

ROUNDS JOINED · USD

$30M

across 1 round

LATEST ROUND

Series A ext. · $30M · 2026-09-28

CO-INVESTORS

named beside it

Rounds

[ 1 ]

The rounds this investor is named on, who it invests beside, and where it shows up.

BMS: 1 round · Fireround

Company	Round	Amount	Announced	Role
Link Cell Therapies An oncology cell therapy company utilizing its proprietary logic-gating technology to develop next-generation CAR-T therapeutics for solid tumors and hematologic malignancies	Series A ext. Developing, 1 source	$30M	2026-09-28	[ PART ]